Alambic Investment Management, L.P. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$364,000
-20.2%
133,384
-3.3%
0.04%
-21.4%
Q1 2017$456,000
+0.4%
137,884
-27.7%
0.06%
-30.9%
Q4 2016$454,000
-26.2%
190,605
+13.8%
0.08%
-44.1%
Q3 2016$615,000
+36.7%
167,505
-17.0%
0.14%
+28.3%
Q2 2016$450,000
-20.8%
201,738
-26.1%
0.11%
-38.6%
Q1 2016$568,000
+30.0%
272,895
+89.4%
0.18%
-30.0%
Q4 2015$437,000144,1000.26%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders